Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites

Eirini P. Papapetrou, Michel Sadelain

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Many applications in human pluripotent stem cell (PSC) research require the genetic modification of PSCs to express a transgene in a stable and dependable manner. Random transgene integration commonly results in unpredictable and heterogeneous expression. We describe a protocol for the derivation of clonal populations of human embryonic stem cells or induced pluripotent stem cells (iPSCs) expressing a transgene from a single copy of an integrated lentiviral vector that is mapped to the genome. Using optimized transduction conditions, followed by single-cell subcloning and a round of antibiotic selection, we find that approximately half of the colonies retrieved contain a single vector copy. After expansion, the majority of these are confirmed to be clonal. The vector/genomic DNA junction is sequenced and the unique integration site is mapped to the genome. This protocol enables the efficient derivation of genetically modified PSCs containing an integrated transgene at a known genomic site in ∼7 weeks.

Original languageEnglish
Pages (from-to)1274-1289
Number of pages16
JournalNature Protocols
Volume6
Issue number9
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites'. Together they form a unique fingerprint.

Cite this